Patents by Inventor Josefin Knutsson

Josefin Knutsson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190358301
    Abstract: A histidine-free composition comprising: a high purity factor VIII (r-factor VIII); arginine and/or sucrose; a surface-active agent to prevent or at least inhibit surface adsorption of factor VIII; an amount of calcium chloride for specific stabilization of factor VIII.
    Type: Application
    Filed: December 20, 2018
    Publication date: November 28, 2019
    Applicant: OCTAPHARMA AG
    Inventors: Brita Rippner, Josefin Knutsson, Ulrika Nilsson, Elsa Ivarsson, Irène Agerkvist
  • Publication number: 20190030169
    Abstract: A method for stabilising a human blood protein or human blood plasma protein with a molecular weight of >10 KDa by adding melezitose to a solution comprising the human blood protein or human blood plasma protein with a molecular weight of >10 KDa.
    Type: Application
    Filed: September 27, 2018
    Publication date: January 31, 2019
    Applicant: OCTAPHARMA AG
    Inventors: Elsa Ivarsson, Josefin Knutsson, Brita Rippner, Ulrika Nilsson, Irène Agerkvist
  • Patent number: 10098956
    Abstract: A method for stabilizing a human blood protein or human blood plasma protein with a molecular weight of >10 KDa by adding melezitose to a solution comprising the human blood protein or human blood plasma protein with a molecular weight of >10 KDa.
    Type: Grant
    Filed: May 17, 2016
    Date of Patent: October 16, 2018
    Assignee: OCTAPHARMA AG
    Inventors: Elsa Ivarsson, Josefin Knutsson, Brita Rippner, Ulrika Nilsson, Irène Agerkvist
  • Patent number: 9943600
    Abstract: A method for stabilising a human blood protein or human blood plasma protein with a molecular weight of >10 KDa by adding melezitose to a solution comprising the human blood protein or human blood plasma protein with a molecular weight of >10 KDa.
    Type: Grant
    Filed: April 4, 2014
    Date of Patent: April 17, 2018
    Assignee: OCTAPHARMA AG
    Inventors: Elsa Ivarsson, Josefin Knutsson, Brita Rippner, Ulrika Nilsson, Irene Agerkvist
  • Publication number: 20170189494
    Abstract: A histidine-free composition comprising: a high purity factor VIII (r-factor VIII); arginine and/or sucrose; a surface-active agent to prevent or at least inhibit surface adsorption of factor VIII; an amount of calcium chloride for specific stabilization of factor VIII.
    Type: Application
    Filed: March 20, 2017
    Publication date: July 6, 2017
    Applicant: OCTAPHARMA AG
    Inventors: BRITA RIPPNER, JOSEFIN KNUTSSON, ULRIKA NILSSON, ELSA IVARSSON, ERÈNE AGERKVIST
  • Publication number: 20160256555
    Abstract: A method for stabilising a human blood protein or human blood plasma protein with a molecular weight of >10 KDa by adding melezitose to a solution comprising the human blood protein or human blood plasma protein with a molecular weight of >10 KDa.
    Type: Application
    Filed: May 17, 2016
    Publication date: September 8, 2016
    Applicant: OCTAPHARMA AG
    Inventors: Elsa Ivarsson, Josefin Knutsson, Brita Rippner, Ulrika Nilsson, Irène Agerkvist
  • Publication number: 20140221290
    Abstract: A method for stabilising a human blood protein or human blood plasma protein with a molecular weight of >10 KDa by adding melezitose to a solution comprising the human blood protein or human blood plasma protein with a molecular weight of >10 KDa.
    Type: Application
    Filed: April 4, 2014
    Publication date: August 7, 2014
    Applicant: OCTAPHARMA AG
    Inventors: Elsa Ivarsson, Josefin Knutsson, Brita Rippner, Ulrika Nilsson, Irene Agerkvist
  • Publication number: 20130116410
    Abstract: A method for stabilising a human blood protein or human blood plasma protein with a molecular weight of >10 KDa by adding melezitose to a solution comprising the human blood protein or human blood plasma protein with a molecular weight of >10 KDa.
    Type: Application
    Filed: April 20, 2011
    Publication date: May 9, 2013
    Applicant: OCTAPH ARMA AG
    Inventors: Elsa Ivarsson, Josefin Knutsson, Brita Rippner, Ulrika Nilsson, Irene Agerkvist